General Studies · Financial Management and Factoring

M/s Global Pharma Inc., an Indian company, receives a substantial order from Dr. K. Mehta, a non-resident individual (NRI) based in the USA, for a bulk supply of medicines. The transaction details are as follows: - 01 January 2025: Global Pharma Inc. delivers the goods worth Rs 15,00,000. Credit term is 90 days. - 01 February 2025: Global Pharma Inc. factors the entire trade receivable of Rs 15,00,000 to a domestic bank, IndiBank, on a Non-Recourse Basis, receiving an advance of 80% of the face value (Rs 12,00,000). - 05 February 2025: Dr. K. Mehta is formally notified by IndiBank of the assignment of the debt. - 20 March 2025: Dr. K. Mehta discovers a quality issue with 10% of the total goods and, based on the original contract, raises a valid claim for a proportionate price reduction of Rs 1,50,000 against Global Pharma Inc. Assuming the payment due date is 01 April 2025, what is the maximum amount that Dr. K. Mehta is legally obligated to pay to IndiBank (the Assignee) on the due date, and what is the maximum Credit Risk borne by IndiBank from Dr. K. Mehta's non-payment?